Navigation Links
Reportlinker Adds World Market for Molecular Diagnostics: Potential and Reality, What's Hot and What's Not , The
Date:3/9/2011

NEW YORK, March 9, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

World Market for Molecular Diagnostics: Potential and Reality, What's Hot and What's Not, The

http://www.reportlinker.com/p0446069/World-Market-for-Molecular-Diagnostics-Potential-and-Reality-Whats-Hot-and-Whats-Not-The.html

There are many sanguine predictions made about the molecular diagnostics but to be useful, context is needed. How can companies sort out what is effective and what is not in this market? For over a decade, Kalorama Information's lead diagnostics analyst Shara Rosen, R.T., MBA has reviewed the molecular diagnostics market. A lot has changed, and a lot has stayed the same. There is intense competition but also opportunities for entrants in some areas. This report The World Market for Molecular Diagnostics: Potential and Reality, What's Hot and What's Not provides current market data for business planning but also goes beyond the numbers to fully assess what is going on in the market.

What are the important developments in the market? Who are the small innovators in this industry and how are the big players reacting to them? Which developments are "hot" - response from providers and payors and which trends have not caught on? In this report, Rosen provides answers to these questions.

The Rewards, Pitfalls and Competition of This High Potential MarketAs we enter the second decade of the 21st century the investment in molecular biology, in bioinformatics, in disease management research and the unraveling of the human genome is bearing fruit. Almost every day the discovery of new molecular markers for cancer, cardiac disease, diabetes, arthritis, neurological diseases and psychiatric conditions are announced.

This title, The World Market for Molecular Diagnostics -Potential and Reality, What's Hot and What's Not provides a detailed examination of molecular testing today. Among the data points the report provides are the following:

  • Current Market Size and Forecast for Molecular Segments (Infectious Disease, Blood Screening, Histology, Oncology, Prenatal, Coagulation, Tissue Typing, Inherited Diseases, Pharmacodiagnostics and Other)
  • Infectious Disease Molecular Sales by Disease (Hepatitis, HIV, GC/Chlamydia, HAI, Respiratory, Organism ID, Mycobacteria/TB, others)
  • Revenues of Top Molecular Diagnostic Companies
  • Recent Mergers and Acquisitions
  • Revenue of Test Service Companies
  • Geographic Breakout of Molecular Diagnostics Market by Region (North America, Europe, Asia, ROW)
  • Sample Prep Market, 2010 and 2015
  • Breakout of Molecular Histology/Cytology Market (in situ hybridization, HPV, Tissue Microarrays), 2010 and 2015
  • Important CLIA Lab Developments, 2008-2010

  • More and more laboratories offer complex panels of tests that help physicians evaluate disease risk and make therapeutic decisions. Government and private healthcare payors have recognized the value of new molecular tools and have agreed to pay for them.

    This renewed interest in IVDs in general and more particularly in molecular diagnostics has lead to the commercialization of a number of technological tools that make more sensitive and specific tests possible. Some of these technological innovations include: cost-effective, multiplexed testing platforms coupled with high-powered software capabilities. In addition analyses using saliva, urine, and blood instead of biopsied tissue make for more patient-friendly test systems.

    To order this report:: World Market for Molecular Diagnostics: Potential and Reality, What's Hot and What's Not, The

    More  Market Research Report

    Check our  Company Profile, SWOT and Revenue Analysis!CONTACT:  Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
    '/>"/>

    SOURCE Reportlinker
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Reportlinker Adds Three Alternative Scenarios of the Future In Vitro Diagnostics Market through 2018
    2. Reportlinker Adds The 2011 Clinical Chemistry and Immunodiagnostics Markets: US, Europe, Japan; Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
    3. Reportlinker Adds The 2011 Top Ten Worlds Leading Life Science Intermediates Companies
    4. Reportlinker Adds Biomarkers - Technologies, Markets and Companies
    5. Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies
    6. Reportlinker Adds RNAi - Technologies, Markets and Companies
    7. Reportlinker Adds Future Outlook for Common IT Platforms - Radiology and Cardiology
    8. Reportlinker Adds The 2011 Blood Banking Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers
    9. Reportlinker Adds Propylene Oxide: 2010 World Market Outlook and Forecast
    10. Reportlinker Adds Global Marine Biotechnology Industry
    11. Reportlinker Adds Global Biotechnology Reagents Industry
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/23/2017)... ... February 23, 2017 , ... ... 12th annual Inventors Recognition Reception at Purdue Research Park of West ... member in recognition of outstanding contributions to, and success with, commercializing discoveries from ...
    (Date:2/23/2017)... Feb. 23, 2017  Capricor Therapeutics, Inc. (NASDAQ: CAPR), a ... conditions, today announced that Linda Marbán, Ph.D, president and chief ... conferences: Cowen and Company 37th Annual ... ET Boston, MA ... am PT (12:00 pm ET) Dana Point, CA ...
    (Date:2/23/2017)... BELLINGHAM, Washington, USA, and CARDIFF, UK (PRWEB) , ... ... ... SPIE, the international society for optics and photonics , have been named Fellows ... each individual’s significant scientific and technical contributions in the multidisciplinary fields of optics, ...
    (Date:2/22/2017)... Santa Clara, CA (PRWEB) , ... February 22, 2017 , ... ... is hosting a free AFM Luncheon for all SPIE attendees ... San Jose, CA, just one block from the San Jose Convention Center. The ...
    Breaking Biology Technology:
    (Date:2/7/2017)... 7, 2017 Ipsidy Inc. ( ... [OTC: IDGS], ("Ipsidy" or the "Company") a provider of ... services, is pleased to announce the following changes as ... Effective January 31, 2017, Philip D. Beck ... and President.  An experienced payment industry professional and public ...
    (Date:2/3/2017)... 3, 2017  Texas Biomedical Research Institute announced that its ... Schlesinger as the Institute,s new President and CEO. Dr. ... 31, 2017. He is currently the Chair of the Department ... for Microbial Interface Biology at Ohio State University. ... President and CEO of Texas Biomed," said Dr. James ...
    (Date:2/2/2017)... , Feb. 2, 2017   TapImmune, ... clinical-stage immuno-oncology company specializing in the development of ... the treatment of cancer and metastatic disease, announced ... and GMP manufacturing of a second clinical lot ... targeting folate receptor alpha. The manufactured vaccine product ...
    Breaking Biology News(10 mins):